Skechers U S A, Inc (SKX) concluded trading on Thursday at a closing price of $75.62, with 4.55 million shares of worth about $343.84 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 25.97% during that period and on February 06, 2025 the price saw a gain of about 1.63%. Currently the company’s common shares owned by public are about 131.59M shares, out of which, 128.95M shares are available for trading.
Stock saw a price change of -3.35% in past 5 days and over the past one month there was a price change of 7.95%. Year-to-date (YTD), SKX shares are showing a performance of 12.46% which increased to 30.00% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $55.67 but also hit the highest price of $78.85 during that period. The average intraday trading volume for Skechers U S A, Inc shares is 1.84 million. The stock is currently trading 3.03% above its 20-day simple moving average (SMA20), while that difference is up 7.95% for SMA50 and it goes to 12.85% higher than SMA200.
Skechers U S A, Inc (NYSE: SKX) currently have 131.59M outstanding shares and institutions hold larger chunk of about 80.63% of that.
The stock has a current market capitalization of $11.42B and its 3Y-monthly beta is at 1.18. PE ratio of stock for trailing 12 months is 18.63, while it has posted earnings per share of $4.06 in the same period. Its PEG reads 1.37 and has Quick Ratio of 1.25 while making debt-to-equity ratio of 0.48. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SKX, volatility over the week remained 2.48% while standing at 2.77% over the month.
Stock’s fiscal year EPS is expected to rise by 11.16% while it is estimated to increase by 17.75% in next year. EPS is likely to grow at an annualized rate of 13.60% for next 5-years, compared to annual growth of 12.67% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on December 10, 2024 offering a Neutral rating for the stock and assigned a target price of $65 to it. On July 23, 2024, Morgan Stanley Upgrade their recommendations, while on June 07, 2024, BofA Securities Upgrade their ratings for the stock with a price target of $87. Stock get an Overweight rating from Barclays on April 01, 2024.
